Jump to content

Search results

Page title matches

  • | generic = 1,4-Butanediol ...
    918 bytes (53 words) - 00:35, 22 May 2026
  • ...al. (2022). Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). ''NEJM'' 387:205. doi:10.1056/NEJMoa2206038</ref> approved for [[cardiova As of 2023, GLP-1 RAs were the largest growth driver in US outpatient medicine spending, Ozem ...
    15 KB (1,939 words) - 18:00, 19 May 2026
  • == Medicines used for Type 1 Diabetes Mellitus == <problemMedicines slug="type-1-diabetes-mellitus" /> ...
    304 bytes (36 words) - 06:05, 13 June 2026

Page text matches

  • == Medicines used for Type 1 Diabetes Mellitus == <problemMedicines slug="type-1-diabetes-mellitus" /> ...
    304 bytes (36 words) - 06:05, 13 June 2026
  • | classes = GLP-1 receptor agonist ...short-acting once-daily injectable [[:Category:GLP-1 receptor agonists|GLP-1 receptor agonist]] approved for type 2 diabetes mellitus. It was approved b ...
    807 bytes (100 words) - 03:16, 19 May 2026
  • [[Category:GLP-1 receptor agonists]] ...
    60 bytes (6 words) - 23:11, 16 May 2026
  • [[Category:GLP-1 receptor agonists]] ...
    62 bytes (6 words) - 23:11, 16 May 2026
  • | classes = Alpha-1 Adrenergic Antagonist | starting_dose = 1 mg at bedtime (PTSD nightmares); 1 mg BID–TID (HTN) ...
    2 KB (211 words) - 03:16, 19 May 2026
  • [[Category:GLP-1 receptor agonists]] ...
    85 bytes (8 words) - 03:16, 19 May 2026
  • [[Category:GLP-1 receptor agonists]] ...
    83 bytes (8 words) - 03:16, 19 May 2026
  • [[Category:GLP-1 receptor agonists]] ...
    85 bytes (8 words) - 03:16, 19 May 2026
  • [[Category:GLP-1 receptor agonists]] ...
    85 bytes (8 words) - 03:16, 19 May 2026
  • [[Category:GLP-1 receptor agonists]] ...
    85 bytes (8 words) - 03:16, 19 May 2026
  • [[Category:GLP-1 receptor agonists]] ...
    85 bytes (8 words) - 03:16, 19 May 2026
  • [[Category:GLP-1 receptor agonists]] ...
    85 bytes (8 words) - 03:16, 19 May 2026
  • [[Category:GLP-1 receptor agonists]] ...
    85 bytes (8 words) - 03:16, 19 May 2026
  • | classes = [[:Category:Alpha-1_blockers|Alpha-1 adrenergic blocker (non-selective)]], [[:Category:BPH_treatments|Benign pro | starting_dose = 1 mg PO at bedtime to limit first-dose syncope; titrate weekly to 5-10 mg ...
    2 KB (219 words) - 10:43, 23 May 2026
  • ...gonist (dextromethorphan)]], [[:Category:Sigma-1_receptor_modulators|Sigma-1 receptor agonist (dextromethorphan)]], [[:Category:CYP2D6_inhibitors|CYP2D6 ...capsule (20/10 mg dextromethorphan/quinidine) PO once daily × 7 days, then 1 capsule BID ...
    3 KB (294 words) - 10:43, 23 May 2026
  • * '''Threshold:''' 0.5-1 mg * '''Light:''' 1-2 mg ...
    2 KB (166 words) - 16:09, 26 May 2026
  • ...8-1 mg/d in pregnancy; 4 mg/d for women with prior NTD-affected pregnancy; 1 mg/d during methotrexate therapy | preparations = 0.4, 0.8, 1 mg OTC; 1 mg Rx; 5 mg/mL injection ...
    2 KB (270 words) - 10:43, 23 May 2026
  • ...= 1 g PO QID on an empty stomach (1 hour before meals and at bedtime); 1 g BID for maintenance | preparations = 1 g tablets; 1 g/10 mL suspension ...
    2 KB (250 words) - 10:43, 23 May 2026
  • | classes = [[:Category:Alpha-1_blockers|Alpha-1 adrenergic blocker (non-selective)]], [[:Category:BPH_treatments|Benign pro | starting_dose = IR 1 mg PO at bedtime, titrate weekly; XL 4-8 mg PO daily ...
    2 KB (243 words) - 10:43, 23 May 2026
  • * Threshold: 500 mcg; Common: 800-1,300 mcg; Strong: 1,200-1,800 mcg; Heavy: 1,600+ mcg ...
    2 KB (213 words) - 16:09, 26 May 2026